- RESEARCH HIGHLIGHT
In patients with resected, high-risk melanoma, the addition of a personalized mRNA-based neoantigen therapy to adjuvant pembrolizumab was more effective than pembrolizumab alone.
By
-
Karen O’Leary
-
Karen O’Leary is an Associate Research Analysis Editor with Nature Medicine.
-
Adjuvant checkpoint inhibitor therapy is the standard of care for resectable melanoma. Although many patients derive lasting benefit from the treatment, a substantial number experience disease recurrence.
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
doi: https://doi.org/10.1038/d41591-024-00006-4
Related Articles
Subjects
Latest on:
Jobs
-
CRAG Director
CRAG is seeking applicants for Director with a distinguished record of scientific excellence, proven leadership and management experience.
Universitat Autònoma de Barcelona (UAB), Bellaterra, Barcelona
Centre de Recerca en Agrigenòmica (CRAG), Consorci CSIC – IRTA – UAB – UB
-
Associate or Senior Editor, Nature Materials
Job Title: Associate or Senior Editor, Nature Materials Locations: Shanghai, Beijing, Milan or Pune - hybrid working model Application Deadline: Ju...
Shanghai, Beijing, Milan or Pune - hybrid working model
Springer Nature Ltd
-
Associate or Senior Editor, Nature Mechanical Engineering
About The Role We are seeking a highly motivated individual to join the launch team of Nature Mechanical Engineering as an Associate or Senior Edit...
Berlin, Heidelberg, Madrid or Milan - Hybrid working model
Springer Nature Ltd
-
Postdoctoral Positions
Postdoctoral positions at Rutgers Cancer Institute, Rutgers University-State University of New Jersey
New Brunswick, New Jersey
Rutgers Cancer Institute
-
Read more research highlights selected by the Nature Medicine team